JIADE Ltd Announces 10:1 Reverse Split and Massive 2 Billion Share Authorization
JDZG has more than doubled off its 52-week low of $1.071.
Summary
JIADE Ltd announced a 10:1 reverse stock split effective June 1, 2026, alongside a massive increase in authorized shares to 2 billion, signaling ongoing efforts to maintain Nasdaq compliance and significant future dilution potential.
Key Events · Financing and Capital Events · JDZG
-
10:1 Reverse Stock Split Announced
The company plans to effect a 10:1 share consolidation (reverse split) effective June 1, 2026. This follows a 1:25 reverse split in March 2026 and another shareholder approval for a reverse split in early May 2026, indicating persistent challenges with Nasdaq listing requirements.
-
Authorized Shares Increased to 2 Billion
JIADE Ltd's authorized share capital will be dramatically increased to 2,000,000,000 shares. This provides the company with substantial headroom for future equity raises, creating significant potential for dilution.
-
Shareholder and Board Approval
The share consolidation and change in authorized share capital were approved by the board of directors on April 20, 2026, and May 12, 2026, and by shareholders on May 4, 2026.
Analysis · JDZG · Trade & Services
This filing finalizes the terms of a new reverse stock split and a dramatic increase in authorized shares, both previously approved in principle. The 10:1 reverse split, effective June 1, 2026, is a direct response to ongoing struggles with Nasdaq listing requirements, following a prior 1:25 reverse split in March. Simultaneously, the company is authorizing 2 billion shares, which represents an enormous potential for future dilution relative to its current market capitalization. This move provides the company with significant flexibility to raise capital through equity offerings, but at the cost of substantial dilution for existing shareholders.
At the time of this filing, JDZG was trading at $4.00 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $61.8M. The 52-week trading range was $1.07 to $116.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.